Faith-based workshops aim to boost cancer screening in muslim women
NCT ID NCT06106165
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a two-hour, peer-led workshop with religious messages could encourage Muslim women in North East England and Scotland to get screened for breast, bowel, and cervical cancer. 169 women aged 25-74 who were not up-to-date with all eligible screenings took part. The goal was to see if the approach is feasible and acceptable, not yet to prove it works. Results will inform a larger future trial.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- peer-led faith-based workshop
- What this could lead to
- If successful, this approach could help increase cancer screening rates among Muslim women, potentially leading to earlier detection and better health outcomes.
- What could go wrong
- This is a small feasibility study, not a full trial. It may not show a clear benefit, and results may not apply to other groups or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
169 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 74 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women from any ethnicity identifying as Muslim * Muslim Women aged 25-74 years * Muslim women living in North East England or Scotland * Muslim women who are not up-to-date with all cancer screening they are eligible for; women who are up-to-date with one type of screening but not others would be eligible (for example, women might be up-to-date with breast cancer screening but not cervical or bowel cancer screening) Exclusion Criteria: * Women who do not identify as Muslim * Women aged less than 25 years or older than 74 years * Women who are up-to-date with all the screening they are eligible for * Women who had either breast, cervical or bowel cancer before as their knowledge of the disease and treatment would differ from other women who do not have any prior experience with the disease * Women who have had BReast CAncer gene testing and underwent mastectomy and/or hysterectomy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bowel cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Glasgow
Glasgow, Scotland, United Kingdom
-
University of Sunderland
Sunderland, Tyne and Wear, SR1 3SD, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?